TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.180
+0.040 (3.51%)
Jul 3, 2025, 1:00 PM - Market closed
Company Description
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States.
It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names.
The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
TherapeuticsMD, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Marlan Walker |
Contact Details
Address: 951 Yamato Road, Suite 220 Boca Raton, Florida 33431 United States | |
| Phone | 561 961 1900 |
| Website | therapeuticsmd.com |
Stock Details
| Ticker Symbol | TXMD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000025743 |
| CUSIP Number | 88338N206 |
| ISIN Number | US88338N2062 |
| Employer ID | 87-0233535 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Marlan D. Walker J.D. | Chief Executive Officer |
| Joseph A. Ziegler | Principal Financial and Accounting Officer |
| Douglas Steelman | Vice President of Market Access |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 13, 2025 | 10-Q | Quarterly Report |
| May 13, 2025 | 8-K | Current Report |
| Apr 30, 2025 | 10-K/A | [Amend] Annual report |
| Apr 9, 2025 | 8-K | Current Report |
| Mar 27, 2025 | 10-K | Annual Report |
| Mar 27, 2025 | 8-K | Current Report |
| Feb 12, 2025 | SCHEDULE 13G | Filing |
| Dec 5, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |